Chrisandra Shufelt, MD, on using a cardiovascular risk score to guide hormone therapy candidacy at menopause.
News|Articles|November 3, 2026
Top video interviews from The Menopause Society 2026 Annual Meeting
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor
A recap of the top video interviews from Contemporary OB/GYN's coverage of The Menopause Society 2026 Annual Meeting in San Diego.
Advertisement
Advertisement
The Menopause Society 2026 Annual Meeting, held October 20-24 in San Diego, California, brought new research and clinical perspectives on menopause care, and the Contemporary OB/GYN team was on location collecting expert interviews. Below, we recap the top video interviews from the month. Visit our
Related to this article
Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.
Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.
Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.
Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.
Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Advertisement
Advertisement